As demonstrated by the data (Fig. 3c, Supplementary Fig. 7a–c), within CD45+ cells, HSD markedly decreased the number of MDSCs (CD11b+Gr-1+ cells) in the blood, spleen and, particularly, tumours. Here, PTPRC is linked to neoplasm.